Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants
Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants
Pleasurable sexual activity is an essential component of many human relationships, providing a sense of physical, psychological, and social well-being. Epidemiological and clinical studies show that depressive symptoms and depressive illness are associated with impairments in sexual function and satisfaction, both in untreated and treated patients. The findings of randomized placebo-controlled trials demonstrate that most of the currently available antidepressant drugs are associated with the development or worsening of sexual dysfunction, in a substantial proportion of patients. Sexual difficulties during antidepressant treatment often resolve as depression lifts but can endure over long periods and may reduce self-esteem and affect mood and relationships adversely. Sexual dysfunction during antidepressant treatment is typically associated with many possible causes, but the risk and type of dysfunction vary with differing compounds and should be considered when making decisions about the relative merits and drawbacks of differing antidepressants. A range of interventions can be considered when managing patients with sexual dysfunction associated with antidepressants, including the prescription of phosphodiesterase-5 inhibitors, but none of these approaches can be considered "ideal." As treatment-emergent sexual dysfunction is less frequent with certain drugs, presumably related to differences in their pharmacological properties, and because current management approaches are less than ideal, a reduced burden of treatment-emergent sexual dysfunction represents a tolerability target in the development of novel antidepressants.
256841
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Palazzo, M.C.
bb51cbd3-aa35-4d4e-a0ea-0930a1c2151e
Masdrakis, V.G.
67ff5fb9-fbf9-4d50-a495-7bf3f4200771
2013
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Palazzo, M.C.
bb51cbd3-aa35-4d4e-a0ea-0930a1c2151e
Masdrakis, V.G.
67ff5fb9-fbf9-4d50-a495-7bf3f4200771
Baldwin, D.S., Palazzo, M.C. and Masdrakis, V.G.
(2013)
Reduced treatment-emergent sexual dysfunction as a potential target in the development of new antidepressants.
Depression Research and Treatment, 2013, .
(doi:10.1155/2013/256841).
(PMID:23431429)
Abstract
Pleasurable sexual activity is an essential component of many human relationships, providing a sense of physical, psychological, and social well-being. Epidemiological and clinical studies show that depressive symptoms and depressive illness are associated with impairments in sexual function and satisfaction, both in untreated and treated patients. The findings of randomized placebo-controlled trials demonstrate that most of the currently available antidepressant drugs are associated with the development or worsening of sexual dysfunction, in a substantial proportion of patients. Sexual difficulties during antidepressant treatment often resolve as depression lifts but can endure over long periods and may reduce self-esteem and affect mood and relationships adversely. Sexual dysfunction during antidepressant treatment is typically associated with many possible causes, but the risk and type of dysfunction vary with differing compounds and should be considered when making decisions about the relative merits and drawbacks of differing antidepressants. A range of interventions can be considered when managing patients with sexual dysfunction associated with antidepressants, including the prescription of phosphodiesterase-5 inhibitors, but none of these approaches can be considered "ideal." As treatment-emergent sexual dysfunction is less frequent with certain drugs, presumably related to differences in their pharmacological properties, and because current management approaches are less than ideal, a reduced burden of treatment-emergent sexual dysfunction represents a tolerability target in the development of novel antidepressants.
Text
DRT2013-256841[1].pdf
- Other
More information
Published date: 2013
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 367930
URI: http://eprints.soton.ac.uk/id/eprint/367930
ISSN: 2090-1321
PURE UUID: ee51146a-a4e9-4f37-a3e4-485198048593
Catalogue record
Date deposited: 26 Aug 2014 16:14
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
M.C. Palazzo
Author:
V.G. Masdrakis
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics